Market closedNon-fractional
Azenta/AZTA
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Azenta
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
Ticker
AZTA
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Burlington, United States
Employees
3,400
Website
www.azenta.com
Azenta Metrics
BasicAdvanced
$2.8B
Market cap
-
P/E ratio
-$2.56
EPS
1.51
Beta
-
Dividend rate
Price and volume
Market cap
$2.8B
Beta
1.51
Financial strength
Current ratio
5.862
Quick ratio
4.81
Long term debt to equity
2.851
Total debt to equity
3.337
Management effectiveness
Return on assets (TTM)
-1.55%
Return on equity (TTM)
-5.95%
Valuation
Price to revenue (TTM)
4.65
Price to book
1.26
Price to tangible book (TTM)
2.21
Price to free cash flow (TTM)
55.18
Growth
Revenue change (TTM)
9.16%
Earnings per share change (TTM)
301.48%
3-year revenue growth
46.93%
3-year earnings per share growth
27.00%
What the Analysts think about Azenta
Analyst Ratings
Majority rating from 7 analysts.
Azenta Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$159M
3.11%
Net income
-$137M
771.34%
Profit margin
-85.98%
745.43%
Azenta Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.13
$0.13
$0.02
$0.05
-
Expected
-$0.02
$0.02
-$0.03
$0.02
$0.08
Surprise
-714.16%
628.99%
-159.88%
167.85%
-
Azenta News
AllArticlesVideos
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
PRNewsWire·4 weeks ago
Azenta to Participate in the Jefferies Global Healthcare Conference
PRNewsWire·1 month ago
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
PRNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Azenta stock?
Azenta (AZTA) has a market cap of $2.8B as of July 04, 2024.
What is the P/E ratio for Azenta stock?
The price to earnings (P/E) ratio for Azenta (AZTA) stock is 0 as of July 04, 2024.
Does Azenta stock pay dividends?
No, Azenta (AZTA) stock does not pay dividends to its shareholders as of July 04, 2024.
When is the next Azenta dividend payment date?
Azenta (AZTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Azenta?
Azenta (AZTA) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Azenta stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.